Colorectal cancer CRC is the third most common cancer and the second leading cause of cancer-related death in the United States. Colonoscopy and fecal immunochemistry testing FIT are the primary recommended CRC screening modalities. The purpose of this study is to improve rates of CRC screening in Veterans and County hospital patients referred to gastroenterology fellow's clinics. A total of 717 patients between ages of 49 and 75 years were seen. Previous CRC screening was not performed in 109 patients 15.2% because of not being offered 73.4% or declining 26.6% screening. Patients who received previous CRC screening compared with no previous screening were older mean age 62.3 years vs. 60.3 years, p <.003, white 88.6% vs. 78.3%, p <.027, and more likely to be Veterans patients 90.8% vs. 77.5%, p <.001. After systematically discussing options for screening with 78 of the 109 unscreened patients, 56 of them 71.8% underwent screening with either colonoscopy 32 or FIT 24. Patients seen by fellows in their last year of training agreed to undergo screening more often than those seen by other fellows 100% vs. 66.2%, p <.033. Systematic discussions about both colonoscopy and FIT can improve the overall rates of CRC screening.
- Fecal immunochemistry testing
- colorectal cancer screening
ASJC Scopus subject areas
- Health Policy
- Public Health, Environmental and Occupational Health